Pre-announced Q4 revenues roughly in line, EBIT 6% below. We cut estimates on soft FY'24 guidance - costs to continue up. Extent of possible SDR synergies still a question mark.
Q3e: revenues down ~4% y-o-y, ~12% EBIT margin. Paper prices flat since June, but limited Q3 impact. Could delay demand recovery; 2% cut to '24e-'25e EBIT.
Q2 revenues 2% below ABGSCe, EBIT 9% below. Signs of improving paper demand positive, but not surprising. '23e-'25e EBIT cut by 1-2%, FVR of DKK 59-98.
Q2e: revenues down ~6% y-o-y, ~17% EBIT margin. Paper prices down >26%, but too early for demand recovery. '23e EPS up 19% on Q2 investment gain; FVR 59-98 (58-96).